A method for the preparation of a transmucosal barrier and immune inducing carrier based on amphoteric mannans
By coupling amphoteric mannan with PLGA copolymer to form a nanoparticle carrier, the problems of penetration of the intestinal mucus layer and immune activation in mucosal delivery systems are solved, achieving efficient mucosal vaccine delivery and immune enhancement effects.
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DALIAN UNIV OF TECH
- Filing Date
- 2026-01-27
- Publication Date
- 2026-06-09
AI Technical Summary
In the existing technology, oral vaccine mucosal delivery systems have difficulty effectively penetrating the intestinal mucus layer and have immunogenicity risks and delivery stability issues. PLGA has a strong hydrophobic surface and lacks immunostimulatory properties, while PEG-mediated cellular uptake capacity is limited.
Amphoteric mannan was coupled with PLGA copolymer and formed into a nanoparticle carrier by ultrasonic self-assembly. The amphoteric mannan on the carrier surface has excellent mucus penetration and cell uptake capabilities, promoting immune activation.
It achieves efficient cross-mucosal delivery, significantly improves mucus penetration ability, promotes cellular uptake and induces mucosal immune enhancement, and has good application prospects.
Smart Images

Figure CN122167750A_ABST